Filing metadata

Accession number
0001214659-24-005217
Form type
Form 4
Filer
CUMBERLAND PHARMACEUTICALS INC
CIK
CIK 1087294
Filed
Mar 26, 2024
Reporting period
Mar 23, 2024
Description
Insider transaction

Explore SEC Filings Hub